Richard Silver
Vice Chair of Development, Department of Medicine · Medical University of South Carolina College of Medicine
Credentials: · · · ·
History
PresentDepartment of Medicine · Medical University of South Carolina College of Medicine
- 1978–1980
Rheumatology
Research
Arthritis & Rheumatism · 2013 · 2,564 citations
Cyclophosphamide versus placebo in scleroderma lung disease
New England Journal of Medicine · 2006 · 1,231 citations
The Lancet Respiratory Medicine · 2016 · 831 citations
36 papers
33 papers
30 papers
26 papers
24 papers
- MB
20 papers · 2 as a fellow
19 papers
18 papers
Grants
- 2024–2026
Development of a Novel Therapeutic Agent for Skin Fibrosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R41
PI · $306.5K · Fibrobiologics, Llc
- 2023–2025
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R41
PI · $299.3K · Fibrobiologics, Llc
- 2021–2023
Preclinical Development of M10 as a Therapeutic Agent for Scleroderma
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R41
Contact PI · $252K · Fibrobiologics, Llc
- 2015–2019
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $326.5K · Medical University of South Carolina
Clinical trials
- 2016–2018
- 2016–2018
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Principal investigator · Completed · Phase 1
Medical University of South Carolina